Program Description & Educational Objectives
In this activity, experts in the management of melanoma discuss the current and evolving set of therapeutic options for the management of malignant disease, focusing on the development and role of novel immunotherapeutic options in the metastatic setting.
Upon completion of this activity, participants will be able to:
- Summarize current practice recommendations for patients with malignant melanoma, including individuals with advanced, unresectable disease
- Demonstrate knowledge of early clinical data on targeted therapy in metastatic melanoma
- Cite the management role of novel immunotherapeutic options in the context of current practice recommendations
- Apply data supporting the use of novel immunotherapeutic options across the spectrum of untreated and previously treated malignant melanoma
Target Audience
This activity has been designed to meet the educational needs of medical oncologists, oncology nurses, pharmacists participating in cancer care, and other professionals involved in the management of patients with malignant melanoma.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE/CPE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Media: Internet
Release and Expiration Dates: May 19, 2011 - May 18, 2012
Time to Complete: 30
Faculty & Disclosure / Conflict of Interest Policy
All faculty AND staff involved in the planning or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.
Course Director and Moderator
Jedd D. Wolchok, MD, PhD
Director, Immunotherapy Clinical Trials
Associate Attending Physician, Melanoma-Sarcoma Service
Associate Director, Medical Oncology-Hematology Fellowship Program
Memorial Sloan-Kettering Cancer Center
New York, New York
Jedd D. Wolchok, MD, PhD,
has a financial interest/relationship or affiliation in the form of:
Advisory Board for Bristol-Myers Squibb.
Interviewee
Steven J. O'Day, MD
Chief of Clinical Research
Director of the Melanoma Program
The Angeles Clinic and Research Institute
Los Angeles, California
Steven J. O'Day, MD,
has a financial interest/relationship or affiliation in the form of:
Consultant for Bristol-Myers Squibb.
Grant/Research Support from Bristol-Myers Squibb.
Speakers Bureau participant with Bristol-Myers Squibb.
Advisory Board for Bristol-Myers Squibb.
Content Director
Carmine DeLuca
PVI, PeerView Institute for Medical Education
Carmine DeLuca
currently has no financial interests/relationships or affiliations in relation to this activity.
All additional planning committee members, PVI, PeerView Institute for Medical Education, Inc. staff, and Purdue University College of Pharmacy staff have no relationships to disclose.
Sponsorship, Credit & Support
Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.
The Purdue University College of Pharmacy designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Purdue University Continuing Nursing Education (CNEP-09, 06/01/2011) is an approved provider of continuing nursing education by the Indiana State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity has been approved for 0.5 contact hour(s).
Note: Not all state nursing boards will accept programs less than 1.0 hour in length for credit. Please click here to find out the status of your state.
Pharmacists
Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based, continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Activity Number (UAN): 0018-9999-11-120-H01-P, 0.5 contact hours (0.05 CEUs).
Release Date: May 19, 2011 Expiration Date: May 18, 2012
This CME/CNE/CPE activity is jointly sponsored by Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education.
This activity is supported by an educational grant from 
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
